Methacholine pre-test asthma probability score in paediatric population

<bold>Background:</bold> Methacholine challenge test (MCT) is a tool used to diagnose airway hyperresponsiveness in asthma. MCT interpretation relies on the patient's pretest asthma probability and the provocative dose(PD20). Yet there is no standardized method for approximating the pre-test probability, which is a challenge in the interpretation process. <bold>Objectives</bold>: Main objective: to standardize a symptom-based pre-test probability score in children referred for a MCT. Secondary objective: to assess the inter-investigator variability of the pre-test probability of asthma. <bold>Methods:</bold> We sent a 10-item medical history and symptoms questionnaire to 42 members of the French Paediatric Lung Function (LF) group and to colleagues abroad engaged in paediatric LF. We used Delphi methodology to guide item selection. In addition, 4 clinical cases were evaluated for pre-test asthma probability. <bold>Results:</bold> We received 23, 20, and 18 responses for the first, second, and third rounds, respectively. Based on these responses, one item was rejected and one was added resulting in a 10-item score that included child and their family's atopic status, the number, type, timing (night or early morning) of respiratory symptoms, their triggers, if any, history of early age (<3years) or recent (within the last 3 years) wheezing, and the effect of anti-asthmatic treatment on symptoms. Responder's pre-test asthma probability (0 to 1) varied across 4 clinical cases as shown in table 1. <bold>Conclusion</bold>: We found essential information for standardizing pre-test asthma probability before MCT in children. The scoring system needs validation against MCT results and final diagnosis. <table-wrap><object-id>erj;64/suppl_68/PA1345/TB1</object-id><object-id>T1</object-id><object-id>TB1</object-id><table><colgroup><col></col><col></col><col></col><col></col></colgroup><tbody><tr><td></td><td>0-0.35</td><td>0.35-0.65</td><td>0.65-1</td></tr><tr><td>case 1</td><td>7</td><td>9</td><td>5</td></tr><tr><td>case 2</td><td>1</td><td>4</td><td>16</td></tr><tr><td>case 3</td><td>3</td><td>10</td><td>8</td></tr><tr><td>case 4</td><td>16</td><td>5</td><td>0</td></tr></tbody></table></table-wrap>

Authors

Institutions

Publication Details

Published
2024-09-14
DOI
https://doi.org/10.1183/13993003.congress-2024.pa1345
Primary Topic
Asthma and respiratory diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Methacholine pre-test asthma probability score in paediatric population

M. Koskas, L Maingot-Sandu, Toni Ibrahim, Nicole Beydon et al.
Asthma and respiratory diseases
article

Methacholine pre-test asthma probability score in paediatric population

M. Koskas, L Maingot-Sandu, Toni Ibrahim, Nicole Beydon, Houda Saleh‐Guillo, Noria Medjahdi, Marie Claude Larocca
article en

Abstract

<bold>Background:</bold> Methacholine challenge test (MCT) is a tool used to diagnose airway hyperresponsiveness in asthma. MCT interpretation relies on the patient's pretest asthma probability and the provocative dose(PD20). Yet there is no standardized method for approximating the pre-test probability, which is a challenge in the interpretation process. <bold>Objectives</bold>: Main objective: to standardize a symptom-based pre-test probability score in children referred for a MCT. Secondary objective: to assess the inter-investigator variability of the pre-test probability of asthma. <bold>Methods:</bold> We sent a 10-item medical history and symptoms questionnaire to 42 members of the French Paediatric Lung Function (LF) group and to colleagues abroad engaged in paediatric LF. We used Delphi methodology to guide item selection. In addition, 4 clinical cases were evaluated for pre-test asthma probability. <bold>Results:</bold> We received 23, 20, and 18 responses for the first, second, and third rounds, respectively. Based on these responses, one item was rejected and one was added resulting in a 10-item score that included child and their family's atopic status, the number, type, timing (night or early morning) of respiratory symptoms, their triggers, if any, history of early age (<3years) or recent (within the last 3 years) wheezing, and the effect of anti-asthmatic treatment on symptoms. Responder's pre-test asthma probability (0 to 1) varied across 4 clinical cases as shown in table 1. <bold>Conclusion</bold>: We found essential information for standardizing pre-test asthma probability before MCT in children. The scoring system needs validation against MCT results and final diagnosis. <table-wrap><object-id>erj;64/suppl_68/PA1345/TB1</object-id><object-id>T1</object-id><object-id>TB1</object-id><table><colgroup><col></col><col></col><col></col><col></col></colgroup><tbody><tr><td></td><td>0-0.35</td><td>0.35-0.65</td><td>0.65-1</td></tr><tr><td>case 1</td><td>7</td><td>9</td><td>5</td></tr><tr><td>case 2</td><td>1</td><td>4</td><td>16</td></tr><tr><td>case 3</td><td>3</td><td>10</td><td>8</td></tr><tr><td>case 4</td><td>16</td><td>5</td><td>0</td></tr></tbody></table></table-wrap>

Sorbonne Université (FR), Hôpital Armand-Trousseau (FR)
Openalex Percentile: Top 73%
Asthma and respiratory diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.